Brief: IQ-AI Reports Promising Preliminary Results Of Phase 1 Study

Imaging Biometrics

11/04/2025 18:00

April 11 (Reuters) - IQ-AI Ltd IQAI.L:

IQ-AI LIMITED  - PROMISING PRELIMINARY RESULTS OF PHASE 1 STUDY

IQ-AI LTD - ORAL GALLIUM MALTOLATE SHOWS EARLY SIGNALS OF EFFICACY

IQ-AI LTD - ORAL GAM SHOWS EXCELLENT TOLERABILITY, NO SERIOUS ADVERSE EVENTS

Source text: ID:nRSK7655Ea

Further company coverage: IQAI.L

 ((Reuters.Briefs@thomsonreuters.com;))